MitoTam (bromide, hydrobromide)
MitoTam bromide, hydrobromide, a Tamoxifen derivative[1], is an electron transport chain (ETC) inhibitor. MitoTam bromide, hydrobromide reduces mitochondrial membrane potential in senescent cells and affects mitochondrial morphology[2]. MitoTam bromide, hydrobromide is an effective anticancer agent, suppresses respiratory complexes (CI-respiration) and disrupts respiratory supercomplexes (SCs) formation in breast cancer cells[1][2].
Product Specifications
CAS Number
1634624-73-9
UNSPSC
12352005
Target
Apoptosis; Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mitotam-bromide-hydrobromide.html
Purity
98.24
Solubility
DMSO : 240 mg/mL (ultrasonic)
Smiles
CN(CCOC1=CC=C(/C(C2=CC=CC=C2)=C(C3=CC=CC=C3)/CCCCCCCCCC[P+](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C=C1)C.Br[H].[Br-]
Molecular Formula
C52H60Br2NOP
Molecular Weight
905.82
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human VCAM-1/CD106 Protein (His Tag)
Recombinant Human VCAM-1/CD106 Protein (His Tag)
Recombinant Human VCAM-1/CD106 Protein (His Tag)
Recombinant Human VCAM-1/CD106 Protein (His Tag)
